MJA
MJA InSight
MJA Careers
Perspectives

Newborn bloodspot screening: setting the Australian national policy agenda

Susannah J Maxwell and Peter O’Leary
Med J Aust 2014; 200 (3): 142-143.
doi:
10.5694/mja13.10974

Australia lags behind other countries in developing a national policy framework for newborn screening

Susannah J Maxwell, BSc, MPH, Research Associate
Peter O’Leary, BSc, PhD, Deputy Director
Centre for Population Health Research, Curtin University, Perth, WA.
Article References: 
Reference Text: 
Australian Law Reform Commission. Essentially yours: the protection of human genetic information in Australia. ALRC Report 96. Canberra: ALRC, 2003. http://www.alrc.gov.au/publications/report-96 (accessed Jun 2013).
Reference Order: 
1
Reference Text: 
Bowman DM, Studdert DM. Newborn screening cards: a legal quagmire. Med J Aust 2011; 194: 319-322.
Reference Order: 
2
Reference Text: 
Royal Australian College of Physicians, Human Genetics Society of Australasia. Newborn bloodspot testing. Policy. August 2011. http://hgsa.org.au/documents/item/29 (accessed Jul 2012).
Reference Order: 
3
Reference Text: 
Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003; 348: 2304-2312.
Reference Order: 
4
PubMed ID: 
12788994
Reference Text: 
Burke W, Tarini B, Press NA, Evans JP. Genetic screening. Epidemiol Rev 2011; 33: 148-164.
Reference Order: 
5
PubMed ID: 
21709145
Reference Text: 
Salveson R. Expansion of the New York State newborn screening panel and Krabbe disease: a systematic program evaluation [PhD thesis]. New York: Columbia University, 2011. http://academiccommons.columbia.edu/download/fedora_content/download/ac:132318/CONTENT/Salveson_columbia_0054D_10227.pdf (accessed Oct 2013).
Reference Order: 
6
Reference Text: 
Ross LF. Newborn screening for lysosomal storage diseases: an ethical and policy analysis. J Inherit Metab Dis 2012; 35: 627-634.
Reference Order: 
7
PubMed ID: 
22189599
Reference Text: 
McNamara S. Lack of screening a “scandal”. MJA Insight 2011; 5 Sep. https://www.mja.com.au/insight/2011/33/lack-screening-scandal (accessed Jul 2013).
Reference Order: 
8
Reference Text: 
Warne GL, Armstrong KL, Faunce TA, et al. The case for newborn screening for congenital adrenal hyperplasia in Australia. Med J Aust 2010; 192: 107.
Reference Order: 
9
Reference Text: 
Cornel M, Rigter T, Weinreich S, et al. Newborn screening in Europe. Expert opinion document. Evaluation of population newborn screening practices for rare disorders in member states of the European Union. 2012. http://ec.europa.eu/eahc/documents/news/Expert_opinion_document_on_NBS_20120108_FINAL.pdf (accessed Oct 2013).
Reference Order: 
10
Reference Text: 
US Department of Health and Human Services. Discretionary Advisory Committee on Heritable Disorders in Newborns and Children. http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders (accessed Oct 2013).
Reference Order: 
11
Reference Text: 
New Zealand Ministry of Health. Newborn metabolic screening: policy framework. Wellington: Ministry of Health, 2011. http://www.nsu.govt.nz/files/ANNB/Newborn_Metabolic_Screening_Programme_Policy_Framework_June_2011.pdf (accessed Jul 2013).
Reference Order: 
12

The full contents of this page are only available to subscribers.